Evidence map›Paper›PMID 24345785›Full record

ArticleMolecular & cellular proteomics : MCP2014

Targeting lipid esterases in mycobacteria grown under different physiological conditions using activity-based profiling with tetrahydrolipstatin (THL).

Madhu Sudhan Ravindran, Srinivasa P S Rao, Xiamin Cheng, Ankit Shukla, Amaury Cazenave-Gassiot, Shao Q Yao, Markus R Wenk

Open access · hybridAbstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Roles of Lipolytic enzymes inFrontiers in microbiology · 2024
    Review
  6. Review
  7. Target Identification in Anti-Tuberculosis Drug Discovery.International journal of molecular sciences · 2023
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Persistence ofFrontiers in cellular and infection microbiology · 2022
    Article
  14. Article
  15. Understanding Metabolic Remodeling inFrontiers in microbiology · 2021
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Madhu Sudhan RavindranNUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, Singapore 117456;
Srinivasa P S Rao
Xiamin Cheng
Ankit Shukla
Amaury Cazenave-Gassiot
Shao Q Yao
Markus R Wenk
Duke-NUS Medical School · SGSwiss Tropical and Public Health Institute · CHNational University of Singapore · SGNovartis (Singapore) · SGUniversity of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tetrahydrolipstatin (THL) is bactericidal but its precise target spectrum is poorly characterized. Here, we used a THL analog and activity-based protein profiling to identify target proteins after enrichment from whole cell lysates of Mycobacterium bovis Bacillus Calmette-Guérin cultured under replicating and non-replicating conditions. THL targets α/β-hydrolases, including many lipid esterases (LipD, G, H, I, M, N, O, V, W, and TesA). Target protein concentrations and total esterase activity correlated inversely with cellular triacylglycerol upon entry into and exit from non-replicating conditions. Cellular overexpression of lipH and tesA led to decreased THL susceptibility thus providing functional validation. Our results define the target spectrum of THL in a biological species with particularly diverse lipid metabolic pathways. We furthermore derive a conceptual approach that demonstrates the use of such THL probes for the characterization of substrate recognition by lipases and related enzymes.

Indexed as

Bacteriological TechniquesDose-Response Relationship, DrugDrug Resistance, BacterialEnzyme ActivationEnzyme InhibitorsEsterasesGene Expression Regulation, BacterialLactonesLipaseLipid MetabolismMolecular Targeted TherapyMycobacterium bovisOrlistatTriglyceridesEnzyme InhibitorsEsterasesLactonesLipaseOrlistatTriglycerides

Identifiers

PMID24345785
PMCPMC3916645
OpenAlexW2155895563

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.